Comparison of outcomes between neoadjuvant imatinib and upfront surgery in patients with localized rectal GIST: An inverse probability of treatment weighting analysis

Author:

Ling Jia‐Yu12ORCID,Ding Miao‐Miao12,Yang Zi‐Feng23,Zhao Yan‐Dong24,Xie Xiao‐Yu12,Shi Li‐Shuo25,Wang Huai‐Ming23,Cao Wu‐Teng26,Zhang Jian‐Wei12,Hu Hua‐Bin12,Cai Yue12,Wang Hui23,Deng Yan‐Hong12

Affiliation:

1. Department of Medical Oncology, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou China

2. Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases Guangzhou China

3. Department of Colorectal Surgery, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou China

4. Department of Pathology, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou China

5. Center for Clinical Research, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou China

6. Department of Radiology, The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou China

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference42 articles.

1. Gain‐of‐function mutations of c‐kit in human gastrointestinal stromal tumors;Hirota S;Science,1998

2. PDGFRA activating mutations in gastrointestinal stromal tumors;Heinrich MC;Science,2003

3. Survival outcomes associated with 3 years vs 1 year of adjuvant imatinib for patients with high‐risk gastrointestinal stromal tumors: an analysis of a randomized clinical trial after 10‐year follow‐up;Joensuu H;JAMA Oncol,2020

4. National Comprehensive Cancer Network (NCCN) Clinical Practice guidelines in Oncology: Gastrointestinal Stromal Tumors (GISTs) (Version 1.2021). Accessed October 30 2020.https://www.nccn.org/store/login/login.aspx?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/gist.pdf

5. Gastrointestinal stromal tumours: ESMO‐EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow‐up;Casali PG;Ann Oncol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3